Tectonic ex-director plans 7,513-share sale
Tectonic Therapeutic, Inc. (TECX) is the issuer of common stock that Terrance Gerard McGuire, a former director, has notified for resale under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tectonic Therapeutic, Inc. (TECX) is the issuer of common stock that Terrance Gerard McGuire, a former director, has notified for resale under Rule 144. The notice covers a proposed sale of 7,513 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $276,718.06 and reference to 19,549,366 shares outstanding as of the notice date. The shares relate to a stock option exercise from the issuer, with cash payment on August 27, 2026. The filing also reports that McGuire previously sold 10,200 shares of common stock during the past three months for $383,670.96 on August 21, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Stock Option Exercise financial
aggregate market value financial
Former Director regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing mean for Tectonic Therapeutic, Inc. (TECX)?
What is the relationship of Terrance McGuire to Tectonic Therapeutic (TECX)?
AI-generated analysis. How Rhea-AI works. Not financial advice.